BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2318917)

  • 1. The management of a hospital formulary.
    Sutters CA
    J Clin Pharm Ther; 1990 Feb; 15(1):59-76. PubMed ID: 2318917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary challenges and novel strategies for health-system formulary management.
    Heindel GA; McIntyre CM
    Am J Health Syst Pharm; 2018 Apr; 75(8):556-560. PubMed ID: 29626005
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventeen years' experience of a voluntarily based drug rationalisation programme in hospital.
    Baker JA; Lant AF; Sutters CA
    BMJ; 1988 Aug; 297(6646):465-9. PubMed ID: 3139150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 8. Formulary compliance and pharmacy labor costs associated with systematic formulary management strategy.
    Helmons PJ; Kosterink JG; Daniels CE
    Am J Health Syst Pharm; 2014 Mar; 71(5):407-15. PubMed ID: 24534596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
    Pedersen CA; Schneider PJ; Santell JP
    Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulary management as a tool to improve medication use and gain physician support.
    Lehmann DF; Guharoy R; Page N; Hirschman K; Ploutz-Snyder R; Medicis J
    Am J Health Syst Pharm; 2007 Mar; 64(5):464-6. PubMed ID: 17322158
    [No Abstract]   [Full Text] [Related]  

  • 11. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2005 Feb; 62(4):378-90. PubMed ID: 15745890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulary management.
    Scroccaro G
    Pharmacotherapy; 2000 Oct; 20(10 Pt 2):317S-321S. PubMed ID: 11034059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of hospital drug policy in the UK.
    Cotter SM; McKee M
    J Health Serv Res Policy; 1997 Jul; 2(3):144-53. PubMed ID: 10180375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and maintenance of an online formulary for a large health system.
    Sears EL
    Am J Health Syst Pharm; 2008 Mar; 65(6):510, 512. PubMed ID: 18319495
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.